Huateng Pharma is able to provide the production of potential COVID-19 drugs Remdesivir intermediates with capacities varying from gram to kilograms.
Merry Christmas and Happy New Year From Huateng Pharma
Welcome To Visit Huateng Pharma (Booth No. W4C02) At CPHI Shanghai 2020 On 16th-18th Dec. 2020
Huateng Pharma was founded in 2013 to manufacture and supply PEG derivatives, pharma APIs & intermediates, biochemical reagents, etc. Today, we operate a 34000m2 industrial park and a 5000m2 R&D base in Changsha, China.
Huateng Pharma provides kinds of boronic acids / boronic ester with high quality and purity.
The new production base has a total land area of 60 acres and a total construction area of 34216 m².
Huateng Pharma is known for a variety of chemical compounds used in research and development, including Boronic Acids/Boronic Esters.
Huateng Pharma is able to provide the production of potential COVID-19 drug Favipiravir API and intermediates with capacities varying from gram to kilograms.
Distinctly dedicated to bringing differentiated and high-quality services to our global clients, Huateng Pharma is a highly proved provider of comprehensive pharmaceutical services.
We are committed to help you in your research by providing necessary drugs which might be useful for coronavirus treatment.
+86 0731 89916275